Japanese pharmaceutical company Taiho Pharmaceutical has formed a corporate venturing subsidiary in California to invest in oncology startups.
Japan-based pharmaceutical firm Taiho Pharmaceutical revealed on Tuesday that it has created a corporate venturing division named Taiho Ventures that will operate from California in the US.
Taiho Ventures has been equipped with $50m in initial funding and was officially established on April 15 run by Sakae Asanuma, former president and CEO of Astellas Venture Management.
The unit will make investments worldwide, focusing on startups in the US, Europe and Japan that are working on cancer-related technologies and treatments.
Potential…
